AppointmentsNew Board Appointments At CBD Firm Voyager

New Board Appointments At CBD Firm Voyager


SCOTTISH CBD firm Voyager has announced three key appointments as it targets fresh distribution channels for its popular range of products and prepares to list on the pan-European Aquis Growth Market in June.

The Perth-based firm set-up in November 2020 by former Zoetic International CEO Nick Tulloch, has appointed two new non-executive directors and a head of sales.

Jill Overland and Nikki Cooper will shortly join the board, while Mark Underwood as head of sales has been charged with finding new outlets for Voyager’s CBD and hemp seed oil products, which are available through its own online portal and more than 20 third-party websites.

Nikki Cooper

Ms Overland has more than 25 years’ experience working in senior finance roles and is currently responsible for finance and corporate services at Cuadrilla. 

Ms Cooper is a qualified solicitor and chartered company secretary, whose career to date has spanned multiple roles, including as a general counsel at Ora Capital Partners, and in corporate finance at N+1 Brewin. 

She also founded her own health supplement brand, Inner Me Limited, following her diagnosis with multiple sclerosis in 2009. The brand successfully gained entry into major retailers, including Boots, Holland and Barrett, Selfridges, Ocado, and on the free-to-air television shopping channel QVC.

Mr Underwood has spent most of his career implementing sales strategies for several blue-chip companies, and was most recently UK sales director in a firm specialising in the CBD market  in the health and wellbeing industry. 

Voyager chairman, Eric Boyle, said the appointments “reflect our robust approach to assurance and compliance as the strong foundations upon which we are building the brand and the business.”

In February, Voyager raised £874,000 through an oversubscribed crowdfunding campaign on Seedrs, and a further £741,000 in April through a private fundraise, including a commitment of £100,000 from Greencare Capital plc, the Aquis-listed investment company focused on medicinal cannabis and related areas.

Jill Overland

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you